Skip to main content

Table 2 Multivariable analysis of factors associated with good or moderate EULAR response at 1 year (n = 172)

From: Predictors of good response to conventional synthetic DMARDs in early seronegative rheumatoid arthritis: data from the ESPOIR cohort

 OR95% CIp
Age > 49 years0.820.35–1.890.64
Sex (female)1.520.51–4.530.45
Education level
 Primary school0.290.08–1.030.06
 Middle school0.530.19–1.460.22
 High schoolref0.23
 University0.730.25–2.150.56
Smoking status
 Current smokingref0.70
 Past smoking0.820.24–2.770.75
 Never smoked1.230.42–3.650.71
DAS28 level  0.71
Tender joint count ≥ 101.210.47–3.140.68
Swollen joint count ≥ 70.940.33–2.690.91
Rheumatologist global assessment ≥ 66/100 (VAS)1.150.51–2.580.74
Early DMARD treatment12.411.07–5.420.03
HAQ-DI ≥ 11.410.67–2.980.37
ESR ≥ 15 mm/h1.420.66–3.030.37
CRP level ≥ 7 mg/l0.710.32–1.610.42
mTSS (per unit)1.000.94–1.070.96
mTSS0.870.30–2.520.79
  1. CRP C-reactive protein, DAS28 Disease Activity Score in 28 joints, ESR erythrocyte sedimentation rate, HAQ-DI Health Assessment Questionnaire-Disability Index, mTSS van der Heijde-modified total Sharp score, VAS visual analog scale, OR odds ratio, 95% CI 95% confidence interval
  2. 1Within 3 months after the first joint swelling